Binding of the experimental dual-action antiparkinsonian drug AG-0029 to dopamine D2 and histamine H3 receptors: a PET study in healthy rats
20200 citationsJournal Article
Field-Weighted Citation Impact: 0.00
Binding of the experimental dual-action antiparkinsonian drug AG-0029 to dopamine D2 and histamine H3 receptors: a PET study in healthy rats | Researchclopedia